Skip to content

Clinical trials

Observational Systemic Inflammatory Response Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Systemic Inflammatory Response Syndrome Phase: Observational Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20151
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital3
Beijing Anzhen Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
Peking University1
Southeast University, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Systemic Inflammatory Response Syndrome7
Sepsis4
Multiple Organ Failure2
Critical Illness1
Disease1
Hemorrhage1
Infections1
Postoperative Complications1
Shock, Septic1
Stomach Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.